Literature DB >> 3259063

Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey.

J Tanaka1, H Nakamura, S Honda, K Takada, S Kato.   

Abstract

Experimental parkinsonism was induced by systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to the crab-eating monkey (Macaca fascicularis). In the acute stage, the substantia nigra showed necrotic nerve cells, extracellular release of pigment granules and histiocytic infiltration. The nerve cells underwent vacuolation of the cytoplasm with chromatin clumping of the nucleus and disintegration of the nucleolus. The striking feature was the presence of variously-shaped inclusion bodies within abnormal mitochondria which sometimes disclosed a distortion of the cristae. Golgi apparatus and endoplasmic reticulum were also dilated. In the locus ceruleus swollen nerve cells were observed with vacuolated cytoplasm and pyknotic nucleus where expanded mitochondria also contained the inclusions. Some of the inclusion bodies are probably insoluble precipitations due to inhibition of mitochondrial oxidation by a certain metabolite of MPTP. In the protracted stage the substantia nigra revealed a considerable loss of the nerve cells associated with melanophagia and astrocytic proliferation. A few surviving nerve cells showed an increased number of Golgi apparatus and rough endoplasmic reticula, and the presence of autophagosomes, dense bodies and intra-mitochondrial inclusion. These changes are interpreted as being a part of the reparative process from the cellular damage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259063     DOI: 10.1007/bf00687790

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Pigment, abnormal mitochondria and laminar bodies in human sympathetic neurons. An electron microscopical study.

Authors:  J Pick
Journal:  Z Zellforsch Mikrosk Anat       Date:  1967

2.  Electron microscopic studies on pigment granules in the substantia nigra and locus coeruleus of the Japanese monkey (Macaca fuscata yakui).

Authors:  K Hirosawa
Journal:  Z Zellforsch Mikrosk Anat       Date:  1968

3.  Pigments in the red nucleus and substantia nigra in man and in representative old and new world monkeys.

Authors:  R C Schwyn; J S King; C A Fox
Journal:  Bol Estud Med Biol       Date:  1970-01

4.  Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors:  G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

5.  Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.

Authors:  C C Chiueh; R S Burns; S P Markey; D M Jacobowitz; I J Kopin
Journal:  Life Sci       Date:  1985-01-21       Impact factor: 5.037

6.  Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.

Authors:  I J Mitchell; A J Cross; M A Sambrook; A R Crossman
Journal:  Neurosci Lett       Date:  1985-10-24       Impact factor: 3.046

7.  Mitochondrial abnormalities in Menkes' kinky hair disease (MKHD). Electron-microscopic study of the brain from an autopsy case.

Authors:  N Yoshimura; H Kudo
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

8.  Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP.

Authors:  R R Ramsay; J Dadgar; A Trevor; T P Singer
Journal:  Life Sci       Date:  1986-08-18       Impact factor: 5.037

9.  The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.

Authors:  G A Donnan; S J Kaczmarczyk; P J Rowe; R Figdor; F A Mendelsohn
Journal:  J Neurol Sci       Date:  1986-06       Impact factor: 3.181

10.  Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain.

Authors:  G R Uhl; J A Javitch; S H Snyder
Journal:  Lancet       Date:  1985-04-27       Impact factor: 79.321

View more
  4 in total

Review 1.  Chronic intraventricular administration of 1-methyl-4-phenylpyridinium as a progressive model of Parkinson's disease.

Authors:  Patricia K Sonsalla; Gail D Zeevalk; Dwight C German
Journal:  Parkinsonism Relat Disord       Date:  2008-06-25       Impact factor: 4.891

2.  Mitochondria covered with a net of parallel and latticed filaments in nigral neurons of monkeys with experimental parkinsonism.

Authors:  H Nakamura; S Kato; J Tanaka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice.

Authors:  K S Rommelfanger; G L Edwards; K G Freeman; L C Liles; G W Miller; D Weinshenker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205

4.  Evolution of nerve fiber degeneration in the striatum in the MPTP-treated squirrel monkey.

Authors:  L S Forno; L E DeLanney; I Irwin; J W Langston
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.